Dr. Theodora Hatziioannou's lab at Rockefeller University focuses on understanding how the body's antiviral defenses impact the ability of lentiviruses, like HIV-1, to infect hosts. By studying how specific proteins in the immune system respond to these viruses, her team aims to identify ways that lentiviruses evade detection and resistance. This research is critical for developing better strategies for preventing and treating HIV-related diseases.

Dr. Charles M. Rice's research lab focuses on viral infections, particularly hepatitis B and various RNA viruses, including coronaviruses. The lab seeks to understand how these viruses interact with host cells, the mechanisms by which the immune system responds to these infections, and how viral pathogenesis occurs at the cellular level. By employing advanced technologies such as RNA sequencing and single-cell analysis, the lab aims to uncover new therapeutic strategies and improve our understanding of viral diseases.

The research lab of Gabriel D Victora at Rockefeller University focuses on understanding how the immune system, particularly B cells, generates antibodies to fight infections and diseases. Their work investigates the mechanisms behind antibody production in the gut, how B cells select specific microbial targets, and how this process contributes to health and disease, such as inflammatory bowel disease and cancer. The lab employs advanced experimental techniques to map the complexities of immune responses, aiming to improve vaccine design and therapeutic strategies.

Dr. Marina Caskey's lab at Rockefeller University focuses on understanding and combating viral infections, particularly HIV and hepatitis B virus (HBV). The lab conducts innovative research to investigate how HIV escapes treatments with broadly neutralizing antibodies (bNAbs) and explores new therapeutic strategies for chronic HBV infection. The goal is to improve immune responses and develop effective treatments that can lead to long-term remission of these viral infections.